<DOC>
	<DOCNO>NCT02151825</DOCNO>
	<brief_summary>The purpose study investigate effect synbiotic ( ProSynbiotic ) gut microbiota composition , body composition adiposity-related gene metabolic marker healthy overweight adult subject .</brief_summary>
	<brief_title>Effect Synbiotic Gut Microbiota Adiposity-related Markers Healthy Overweight Subjects</brief_title>
	<detailed_description>This parallel , double-blind , randomize , placebo control trial determine effect synbiotic formulation ( ProSynbiotic ) contain 4 billion CFU probiotic blend Bifidobacterium lactis BB-12 , Lactobacillus acidophilus LA-5 , Lactobacillus casei 431 Saccharomyces boulardii , along 1 g prebiotic inulin 100 mg galactooligosaccharide ( GOS ) gut microbiota composition , body composition , expression gene mediate dietary energy harvest adiposity , adiposity-related metabolic marker healthy free-living overweight moderately obese subject . The duration study 18 week , include 2-week run-in period randomization subject synbiotic placebo group , 12-week intervention period , 4-week follow-up end intervention . During intervention period , subject instructed take 3 capsule either synbiotic placebo per day maintain habitual diet physical activity . They also ask document unusual symptom side effect well keep bowel diary . Diet physical activity monitor via 24-h dietary recall global physical activity questionnaire respectively . Changes gut microbiota composition determine measure bacterial population level stool sample collected baseline , 6 week , 12 week follow time point . Body composition measure use BOD POD baseline , 6 week , 12 week . Gene expression level assess baseline 12 week colonocytes ( isolated stool sample ) PBMCs ( isolate blood sample ) qPCR . Metabolic marker measure baseline 12-weeks plasma serum use respective biochemical- immuno-assays .</detailed_description>
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<criteria>Age 1864 BMI 2534.9 and/or waist circumference &gt; 35 inch woman &gt; 40 inch men Generally healthy except overweight moderately obese A signed consent form Passed screen questionnaire willingness comply study procedure Lipid level , fast glucose , liver function complete blood count within normal reference range measure screen blood sample Persons weightloss regimen Antibiotic use ( &lt; 3 month study ) Regular probiotic , prebiotic synbiotic use ( &lt; 1 month study ) Regular use antiinflammatory drug , weightloss medication supplement ( &lt; 1 month prior study ) Personal history cardiovascular disease , hypertension , cancer , type 1 type 2 diabetes inflammatory gastrointestinal disorder Crohn 's disease colitis Smoking Consumption &gt; 2 unit alcohol per day Pregnancy lactation Irregular period , menopause hormone replacement therapy Over 300 minute exercise per week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Gut microbiota</keyword>
	<keyword>Probiotics</keyword>
	<keyword>Prebiotics</keyword>
	<keyword>Synbiotic</keyword>
	<keyword>Bifidobacterium lactis BB-12</keyword>
	<keyword>Lactobacillus acidophilus LA-5</keyword>
	<keyword>Lactobacillus casei 431</keyword>
	<keyword>Inulin</keyword>
	<keyword>GOS</keyword>
	<keyword>Body Weight</keyword>
	<keyword>Overweight</keyword>
	<keyword>Adiposity</keyword>
	<keyword>Obesity</keyword>
	<keyword>ANGPTL4</keyword>
</DOC>